In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc. (NYSE:PFE) has agreed to ...
Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its ...
Pfizer (NYSE:PFE) will pay up to $250M to settle more than 10,000 U.S. lawsuits alleging that the company concealed cancer ...
Financial terms of the settlements were not immediately disclosed for the discontinued over-the-counter drug that was used to treat heartburn ...
Cook County jury rules heartburn medication Zantac not responsible for plaintiff's cancer; Pfizer settles over 10,000 ...
Pfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer ...
The jury in Cook County, Illinois circuit court agreed with arguments from drugmakers GSK and Boehringer Ingelheim that the ...
In the first personal injury case that has gone to trial over Zantac, GSK and Boehringer Ingelheim have emerged with an important victory as a Chicago jury has rejected the claim of Angela Valadez ...
Chicago: A jury in Chicago delivered a verdict on Thursday, dismissing the claim of an Illinois woman who alleged that the ...
A Chicago jury dismissed claims by Angela Valadez that the heartburn drug Zantac caused her colon cancer. The trial marks the first of many similar lawsuits. Drugmakers GSK and Boehringer Ingelheim ...
Brazil's Superior Court of Justice has denied state-run oil company Petrobras an appeal against the collection of some 987 ...
Recent health news covers various incidents, including a fire at Novo Nordisk’s headquarters, mergers by Gerresheimer and Biogen, avian flu cases in humans, and lawsuits against Johnson & Johnson.